These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15862802)

  • 21. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.
    Göktalay G; Cavun S; Levendusky MC; Hamilton JR; Millington WR
    Eur J Pharmacol; 2006 Jan; 530(1-2):95-102. PubMed ID: 16364288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
    Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
    Rasmussen K; Hsu MA; Vandergriff J
    Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of dorsal hippocampal nicotinic receptors in the effect of morphine on memory retrieval in passive avoidance task.
    Khajehpour L; Rezayof A; Zarrindast MR
    Eur J Pharmacol; 2008 Apr; 584(2-3):343-51. PubMed ID: 18316071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bupropion attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.
    Shytle RD; Silver AA; Sheehan KH; Sheehan DV; Sanberg PR
    Depress Anxiety; 2002; 16(3):89-92. PubMed ID: 12415531
    [No Abstract]   [Full Text] [Related]  

  • 27. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke.
    Simons CT; Cuellar JM; Moore JA; Pinkerton KE; Uyeminami D; Carstens MI; Carstens E
    Neurosci Lett; 2005 Dec; 389(2):71-6. PubMed ID: 16095820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Ise Y; Narita M; Nagase H; Suzuki T
    Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
    Sidhpura N; Redfern P; Rowley H; Heal D; Wonnacott S
    Biochem Pharmacol; 2007 Oct; 74(8):1292-8. PubMed ID: 17678630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of postsynaptic density proteins in the hippocampus of rat offspring from the morphine-addicted mother: Beneficial effect of dextromethorphan.
    Yang SN; Liu CA; Chung MY; Huang HC; Yeh GC; Wong CS; Lin WW; Yang CH; Tao PL
    Hippocampus; 2006; 16(6):521-30. PubMed ID: 16598705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.
    Struthers AM; Wilkinson JL; Dwoskin LP; Crooks PA; Bevins RA
    Pharmacol Biochem Behav; 2009 Dec; 94(2):319-28. PubMed ID: 19778551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
    Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
    Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory influence of mecamylamine on ethanol withdrawal-induced symptoms in C57BL/6J mice.
    Bhutada PS; Mundhada YR; Bansod KU; Umathe SN; Kahale VP; Dixit PV; Mundhada DR
    Behav Pharmacol; 2010 Mar; 21(2):90-5. PubMed ID: 20168214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
    Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
    Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dextrorotatory morphinans on alpha3beta4 nicotinic acetylcholine receptors expressed in Xenopus oocytes.
    Lee JH; Shin EJ; Jeong SM; Kim JH; Lee BH; Yoon IS; Lee JH; Choi SH; Lee SM; Lee PH; Kim HC; Nah SY
    Eur J Pharmacol; 2006 Apr; 536(1-2):85-92. PubMed ID: 16563374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
    Sidhpura N; Redfern P; Wonnacott S
    Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents.
    Kuehne ME; He L; Jokiel PA; Pace CJ; Fleck MW; Maisonneuve IM; Glick SD; Bidlack JM
    J Med Chem; 2003 Jun; 46(13):2716-30. PubMed ID: 12801235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.